Sign in
  • Home
  • Conference
    • Conference Home
    • Register for EGC 92
    • Conference Highlights
    • Presenter Testimonials
    • All Conferences
  • Directory
    • Directory Home
    • Law Firms
    • Accountants / Auditors
    • Investment Banks
    • Investor Relations
    • News Wires
    • Transfer Agents
    • Technology Providers
  • Resources
    • Caveat Emptor Status
    • Market Movers
  • Cryptocurrency
    • Crypto in the News
    • Cryptocurrency list
    • Crypto Exchanges
    • Past ICO’s
    • Ongoing ICO’s
    • Upcoming ICO’s
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
Logo
Medical Marijuana Stocks Emerging Growth News

Logo

  • Home
  • Conference
    • Conference Home
    • Register for EGC 92
    • Conference Highlights
    • Presenter Testimonials
    • All Conferences
  • Directory
    • Directory Home
    • Law Firms
    • Accountants / Auditors
    • Investment Banks
    • Investor Relations
    • News Wires
    • Transfer Agents
    • Technology Providers
  • Resources
    • Caveat Emptor Status
    • Market Movers
  • Cryptocurrency
    • Crypto in the News
    • Cryptocurrency list
    • Crypto Exchanges
    • Past ICO’s
    • Ongoing ICO’s
    • Upcoming ICO’s

Graphene enhanced concrete continues to excel in field trials

admin 0
Highlights Graphene enhanced concrete slab continues to perform well after >200 days in the field at a major UK highway infrastructure project Strength and...

Significant efficiency improvements achieved at Henderson graphene manufacturing facility

New opportunities in green hydrogen production following positive electrocatalyst results

Successful production of graphene oxide opens up new growth curve ,...

Extending Commercialisation of PureGRAPH across a wide range of industries

AD-214 RETURNS TO CLINICAL STUDIES

Unlocking Chronic Diseases with Next-Gen i-body Platform Technology from AdAlta (1AD)

$1.87 million raised in oversubscribed Shortfall facility

New AD-214 Data Links Phase I Results With Efficacy; De-Risks Clinical...

AdAlta (ASX: 1AD) IMPORTANT PHASE I EXTENSION CLINICAL STUDY OF AD-214...

A Diamond in the Rough of Diamond Stocks

Lucapa Diamond Co. (ASX: LOM) THIRD +100 CARAT DIAMOND RECOVERED FROM...

Lucapa Diamond Co. (ASX: LOM) LULO Diamonds Sell For A$4.6M

Lucapa Diamond Co (ASX: LOM) 215 CARAT DIAMOND RECOVERED AT MOTHAE

First Graphene Limited (ASX: FGR) New CEO Sets Sights on Commercial...

Lucapa Diamond Co. (ASX: LOM) Announces LULO DIAMONDS SELL FOR A$7.7M

First Graphene, LTD (ASX: FGR) December Quarterly Activities Review

First Graphene (ASX: FGR) Extracts True Practicality from Rising Innovations

Emerging Growth Report; First Graphene (ASX: FGR) Is on the Cusp...

Facebook
Instagram
Linkedin
X
Youtube

About Us

The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

Contact us:
305-330-1985
[email protected]

Directory

Law Firms
Accountants / Auditors
Investment Banks
Investor Relations
News Wires
Transfer Agents

Investor Tools

We Buy Penny Stocks
Market Movers
Caveat Emptor Status Changes
Cryptocurrency Center

Public Companies

Emerging Growth Investor Relations
Brand Ambassador & Talent

Presenter Testimonials

Conference Highlights

  • Disclosure
  • Terms of Use
  • Privacy Policy
  • Contact Us / Subscribe

© Copyright 2009-2026 - EmergingGrowth.com -- Images via Shutterstock -- Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. Data delayed 15 minutes unless indicated. Electronic EG content as further described in our disclosure (link on the bottom of every page) is for informational purposes only and does not reflect the opinions of EmergingGrowth.com or any of its affiliates. All viewers of EmergingGrowth.com content a. understand and agree that such content does not represent trading or investment advice, and b. agree that they will not hold EmergingGrowth.com or any of its affiliates or subsidiaries liable for any loss or damage caused by your reliance on information contained within.